Molecular, biochemical and biophysical aspects of sickle cell disease (SCD) have been studied extensively by researchers from various fields in the past 20 years. However, factors that initiate sickling in vivo are not well understood, and the relationship between sickling and the pathophysiology of SCD is unclear. In addition, no safe, effective means of preventing sickling or reversing already sickled cells in vivo, has been found, and the development and testing of antisickling agents is complicated by difficulties involved with clinical trials. One of the main constraints in studying SCD has been the lack of animal models. Animal models for SCD would be extremely helpful to study the initiation of vasoocclusive crises, pathological consequences of deformed cells, and the effects of antisickling agents in vivo. Rapid advances in molecular biology and transgenic technology have made possible the long-pursued goal of an animal model for SCD. Although numerous applications can be considered for experimental use of transgenic mice that produce Hb S (Tg-Hb S) mice, we will focus on four specific aims. We will first perform studies to examine basic biochemical and biophysical properties of various mixtures of mouse and human hemoglobins including measurements of solubility and gelation kinetics of Hb S in the presence of various mouse hemoglobins. These studies will provide us with important information regarding the influence of endogenous mouse hemoglobins on the polymerization of Hb S and the sickling properties of mouse RBC. Sickling properties of RBC containing various levels of human beta-s-globin and different mouse alpha- and beta-globin will be investigated under various hypoxic conditions. The size, shape and percentage of sickled cells will be analyzed quantitatively using a computer-assisted image analysis system. We will study various hematological parameters and pathological changes after exposure of Tg-Hb S mice to of hypoxic, hyperthermic and dehydration stress. Another important application of the Tg-Hb S mice is for screening and evaluation of antisickling agents, at both the cellular level and the whole body level. Since RBC from Tg-Hb S mice, with more than 50% human beta-s sickle almost completely upon deoxygenation, such animals could provide a readily available laboratory source for screening of new antisickling agents. Preliminary studies with several antisickling agents showed that the compounds inhibit sickling of Tg-Hb S mouse RBC as well human SS cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
2P60HL038632-06
Application #
3780628
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ballas, Samir K; Connes, Philippe; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (2018) Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and ?-thalassemia. Eur J Haematol 101:798-803
Kwiatkowski, Janet L; Zimmerman, Robert A; Pollock, Avrum N et al. (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146:300-5
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Kiryu, Shigeru; Sundaram, Tessa; Kubo, Shigeto et al. (2008) MRI assessment of lung parenchymal motion in normal mice and transgenic mice with sickle cell disease. J Magn Reson Imaging 27:49-56
Niebanck, Alison E; Pollock, Avrum N; Smith-Whitley, Kim et al. (2007) Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr 151:67-72, 72.e1
Uematsu, Hidemasa; Takahashi, Masaya; Hatabu, Hiroto et al. (2007) Changes in T1 and T2 observed in brain magnetic resonance imaging with delivery of high concentrations of oxygen. J Comput Assist Tomogr 31:662-5
Obata, Kazuo; Mattiello, Julian; Asakura, Kenji et al. (2006) Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes. Am J Hematol 81:26-35
Akbar, Mohammed G K; Tamura, Yutaka; Ding, Min et al. (2006) Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide. Biochemistry 45:8358-67
Adachi, Kazuhiko; Ding, Min; Surrey, Saul et al. (2006) The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism. J Mol Biol 362:528-38
Asakura, Toshio; Asakura, Kenji; Obata, Kazuo et al. (2005) Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 80:249-56

Showing the most recent 10 out of 140 publications